Cargando…
Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers
Glucocorticoids (GC) induce cardiometabolic risk while atherosclerosis is a chronic inflammation involving immunity. GC are immune suppressors, and the adrenocorticotrophic hormone (ACTH) has immune modulator activities. Both may act in atherothrombotic inflammation involving immune cells (IMNC). Ai...
Autores principales: | Aranda, Gloria, Lopez, Cristina, Fernandez-Ruiz, Rebeca, Esteban, Yaiza, Garcia-Eguren, Guillermo, Mora, Mireia, Halperin, Irene, Casals, Gregori, Enseñat, Joaquim, Hanzu, Felicia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632466/ https://www.ncbi.nlm.nih.gov/pubmed/29213284 http://dx.doi.org/10.1155/2017/2912763 |
Ejemplares similares
-
OR03-05 Novel Lipidome Signature in Active Cushing Syndrome Revealed by UHPLC-MS Metabolomics
por: Vega-Beyhart, Arturo, et al.
Publicado: (2020) -
Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?
por: Casals, Gregori, et al.
Publicado: (2020) -
Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome
por: Vega-Beyhart, Arturo, et al.
Publicado: (2022) -
RF21 | PSAT99 Urinary adrenal steroidome modifications by Ketoconazole and Metyrapone alter the urinary free cortisol immunoassay reliability in Cushing Syndrome
por: Vega-Beyhart, Arturo, et al.
Publicado: (2022) -
Onset of fulminant type 1 diabetes mellitus following hypophysitis after discontinuation of combined immunotherapy. A case report
por: Boswell, Laura, et al.
Publicado: (2021)